[1]周晴晴,李慧杰,李秀荣△.基于癌毒理论探讨攻毒治法抗肿瘤血管生成*[J].陕西中医,2020,(8):1134.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.033]
　ZHOU Qingqing,LI Huijie,LI Xiurong..Discussion on anti-tumor angiogenesis by therapeutics of eliminating toxin based on cancer toxin theory[J].,2020,(8):1134.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.033]
点击复制

基于癌毒理论探讨攻毒治法抗肿瘤血管生成*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年8期
页码:
1134
栏目:
学术探讨
出版日期:
2020-08-05

文章信息/Info

Title:
Discussion on anti-tumor angiogenesis by therapeutics of eliminating toxin based on cancer toxin theory
作者:
周晴晴1; 李慧杰2; 李秀荣2△
1.山东中医药大学第一临床医学院(济南 250355); 2.山东中医药大学附属医院(济南 250014)
Author(s):
ZHOU Qingqing; LI Huijie; LI Xiurong.
The First Clinical Medical College of Shandong University of Traditional Chinese Medicine(Jinan 250355)
关键词:
癌毒理论;  攻毒治法;  攻毒类中药;  络病;  痰瘀郁毒;  抗肿瘤血管生成
Keywords:
Cancer toxin theory;  Therapeutics of liminating toxin;  Chinese medicinal of counteracting toxic substances;  Collateral disease;  Phlegm and blood stasis stagnant toxin;  Anti-tumor angiogenesis
分类号:
R273
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.033
文献标志码:
A
摘要:
癌毒是贯穿恶性肿瘤发生发展过程始终的一种特异致癌性毒邪,是多种因素作用下的内生性复合病理因素,也是肿瘤血管生成的重要前提。当人体阴阳失和,脏腑功能失调,气血郁滞,癌毒内生,瘀血、痰浊、湿毒等诸邪结于络道,络道亢进,增生无制,病络生成,这与肿瘤患者病态微循环的建立极为相似。攻毒治法是基于癌毒病机理论采用攻毒类中药,以清热解毒、活血化瘀、化痰祛湿、破血消癥、豁痰开瘀、软坚散结、消积导滞、泻下攻积、通里攻下、祛腐蚀疮和拔毒生肌等治疗肿瘤的治疗大法,结合肿瘤血管生成之“痰瘀郁毒”的核心病机,抗肿瘤血管生成常从清热解毒、活血化瘀、化痰散结三法入手。本文从古今文献记载、病因病机分析、攻毒机制剖析、现代实验研究等方面论证攻毒治法抗肿瘤血管生成行之有效。
Abstract:
Cancer toxin is a specific carcinogenic toxin that runs through the occurrence and development of malignant tumor.It is not only an endogenous compound pathological factor under the action of many factors,but also an important prerequisite for tumor angiogenesis.When the human body is out of harmony with yin and yang,viscera function imbalance,qi and blood stagnation,cancer toxin endogenesis,blood stasis,phlegm turbidity,dampness toxin and other evil knot in the collaterals,hyperactivity of collaterals,uncontrolled proliferation,and the formation of diseased collaterals,which is very similar to the establishment of pathological microcirculation in tumor patients.The method of attacking poison is based on the pathogenesis theory of cancer toxin,using traditional Chinese medicine to clear heat and detoxification,promoting blood circulation and removing blood stasis,resolving phlegm and dampness,breaking blood and eliminating blood stasis,dispelling phlegm and blood stasis,dispelling stagnation,purging and attacking accumulation,Tongli attacking,removing corrosive sores and removing toxin and promoting muscle,etc. Combined with the core pathogenesis of “phlegm,blood stasis and stagnation” of tumor angiogenesis,anti-tumor angiogenesis often starts with three methods:clearing heat and detoxification,promoting blood circulation and removing blood stasis,and resolving phlegm and dispersing knots.This paper demonstrates that the method of attacking virus is effective in anti-tumor angiogenesis from the aspects of ancient and modern literature records,etiology and pathogenesis analysis,virus attack mechanism analysis,modern experimental research and so on.

参考文献/References:

[1] 杨 彦,杨 羚.基于“毒-虚-瘀”探讨肿瘤血管生成的中医机制[J].成都中医药大学学报,2017,40(3):115-116.
[2] 郑文利,李慧杰,裴 可,等.基于癌毒理论探讨攻毒类中药在恶性肿瘤治疗中的应用[J].中医药信息,2019,36(4):98-102.
[3] 张继泽,邵荣世,单兆伟.张泽生医案医话集[M].南京:江苏科学技术出版社,1981:341.
[4] 程海波,吴勉华.周仲瑛教授“癌毒”学术思想探析[J].中华中医药杂志,2010,25(6):866-869.
[5] 霍 达,任 明,宋春燕,等.癌毒理论研究及其对癌肿辨证施治的指导[J].中国中医药现代远程教育,2018,16(18):66-69.
[6] 凌昌全.“癌毒”是恶性肿瘤之根本[J].中西医结合学报,2008,6(2):111-114.
[7] Folkman J.Tumor angiogenesis:therapeutic implications[J].The New England Journal of Medicine,1971,285(21):1182-1186.
[8] Rong P,Yue D,Xing HG,et al.Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways[J].Vascular Pharmacology,2011,54(1-2):18-28.
[9] 奚胜艳,高学敏,张建军,等.从中医络病与病络理论认识肿瘤血管生成[J].北京中医药大学学报,2008,31(12):804-807,822.
[10] 刘娇萍,袁昌劲,曹继刚,等.从中医象思维认识肿瘤血管生成[J].中国中医基础医学杂志,2019,25(7):937-938,943.
[11] 清?程国彭.医学心悟[M].北京:科学技术文献出版社,1996:26,29.
[12] 王中泰,吴 芳,颜彬桔,等.进展期非小细胞肺癌抗血管生成治疗进展[J].中国肿瘤临床,2018,45(19):973-979.
[13] 刘升长,朱金华,侯吉华,等.虫类药活血功效及抗肿瘤应用探析[J].亚太传统医药,2015,11(19):52-54.
[14] 徐辉碧.雄黄抑制小鼠肉瘤S180的尺寸效应的初步研究[J].武汉大学学报,2000,46(3):288.
[15] 李秀荣,李慧杰,林艳艳.纳米雄黄抑制A431细胞株新生血管的机制研究[J].现代肿瘤医学,2013,21(2):232-234.
[16] 齐元富,李慧杰,于连洋.纳米雄黄干预肺癌A549细胞对血管内皮生长因子及缺氧诱导因子-1表达的影响[J].中国老年学杂志,2015,35(3):720-722.
[17] 王文江,孙 珏.活血化瘀防治恶性肿瘤侵袭转移研究进展[J].江西中医药,2013,44(7):69-73.
[18] 林晓燕,宋和平,胡赟宏.去甲斑蝥素对人乳腺癌血管生成的抑制作用[J].中国癌症杂志,2007,17(11):847-850.
[19] 杜恒飞,于路佳,郝京生,等.去甲斑蝥素对多发性骨髓瘤细胞周期和血管内皮细胞生长因子的影响[J].山东医药,2012,52(1):22-24.
[20] Yu T,Hou F,Liu M,et al.Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer[J].Asian Pacific Journal of Cancer Prevention,2012,13(2):499-503.
[21] 郭梦丽,王建刚,靳 颖.壁虎醇提物对H22肝癌血管新生的抑制作用[J].中国临床药理学杂志,2016,32(24):2282-2285.
[22] 葛文静,段冷昕,刘 玲,等.壁虎醇提物抑制人宫颈癌SiHa细胞迁移及侵袭的研究[J].中国临床药理学杂志,2016,32(10):913-916.
[23] 黄煜伦,周幽心,周 岱,等.雷公藤红素抑制血管生成的实验研究[J].中华肿瘤杂志,2003,29(5):17-20.
[24] 姜 华,孙成法,褚荣涛,等.雷公藤红素对荷瘤裸鼠移植瘤生长及血管生成的影响[J].中国实用神经疾病杂志,2014,17(24):1-3.
[25] Gao YF,Zhou S,Pang LZ,et al.Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer[J].Free Radical Research,2019,53(3):324-334.
[26] 李 涛.重楼总皂苷抗肿瘤机制研究[D].西安:陕西师范大学,2013.
[27] 齐元富,李慧杰,李 静.六神丸对H22肝癌腹水移植瘤PDGF与VEGF表达的影响及相关机制探讨[J].世界中医药,2013,8(1):69-71.
[28] 张 慧,黄立中,田 莎,等.构建食管癌移植瘤模型及不同剂量六神丸干预后的微血管密度变化[J].中国组织工程研究,2015,19(5):766-771.
[29] 胡 叶,周 琴,李善君,等.华蟾素注射液干预血管内皮细胞和肿瘤细胞增殖及VEGF表达的实验研究[J].实用癌症杂志,2019,34(1):1-4.

相似文献/References:

[1]郭天灏,周红光△,霍介格.基于癌毒理论探讨肿瘤患者兼见不寐的相关治疗*[J].陕西中医,2020,(10):1455.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.032]

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81503542)；山东省重点研发计划项目(2018GSF119016)
更新日期/Last Update: 2020-08-10